Loading...
•
Dec 31, 2022
Teladoc Q4 2022 Earnings Report
Teladoc Health's Q4 2022 earnings were released, showing revenue growth but a significant net loss due to goodwill impairment charges.
Key Takeaways
Teladoc Health reported a 15% increase in revenue for Q4 2022, reaching $637.7 million. However, the company experienced a net loss of $3,810.1 million, or ($23.49) per share, primarily due to non-cash goodwill impairment charges of $3.8 billion.
Revenue grew 15% year-over-year to $637.7 million.
Net loss per share was ($23.49), driven by non-cash goodwill impairment charges.
Adjusted EBITDA increased 22% to $94.1 million.
U.S. revenues grew 15% and International revenues grew 17%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provided financial outlook for Q1 2023 and full year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...